[SCHEDULE 13G/A (Amendment No. 1) Himax Technologies, Inc. (Name of Issuer) ADR (Title of Class of Securities) 43289P106 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) x Rule 13d-1(b) o Rule 13d-1(c) o Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form]
[CUSIP No 16950M107 1. NAME OF REPORTING PERSONS]
[(Name of Issuer) Common Stock (Title of Class of Securities) 83408W103 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * CUSIP No. 83408W103 1. NAMES OF REPORTING PERSONS 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 3. SEC USE ONLY]
[1 This CUSIP number applies to the Issuers American Depositary Shares, each representing one Ordinary Share. CUSIP No. 98584B 103hedule 13G 1 Names of Reporting Persons 2 Check the Appropriate Box if a Member of a (See Instructions) (a) o (b) x 3 SEC Use Only 4 Citizenship or Place of Organization] [Joint Filingreement Remainder of this pagehas been left intentionally blank [ 3 . Liansheng Miao Liansheng Miao Yingli Powermpany Limited Christina Choo &ice Yap Christina Choo &ice Yap Authorized Signatories For and on behalf of Kendrick Services Limitedrporate Director Whitehallsetss Limited Christina Choo &ice Yap]
[Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 7,470,815 Item 6: 0 Item 7: 8,643,315 Item 8: 0 Item 9: 8,643,315 Item 11: 18.371% Item 12: HC Cusip #64118U926 Item 1: Reporting Person - Edward C. Johnson 3d Item 5: 0 Item 6: 0 Item 7: 8,643,315 Item 8: 0 Item 9: 8,643,315 Item 11: 18.371%]
[*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to]
[Xiangdong Qi (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ¨ (b) x (3) SEC USE ONLY]
[(Name of Issuer) Common Stock (Title of Class of Securities) P8696W104 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * CUSIP No. P8696W104 1. NAMES OF REPORTING PERSONS 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 3. SEC USE ONLY]
[FORM 10-Q (Mark One) x For the quarterly period ended December 31, 2012 o For the transition period from _______________ to _______________ Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of incorporation or organization) 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 +0086-028-86154737 (Address, including zip code, and telephone number,] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended December 31, 2012 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended December 31, 2012 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2)T he information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer, Chief Accounting Officer, Chairman] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong Chief Financial Officer, Director]
